FDA misses congressional deadline to update clinical trial diversity guidance
Regulatory NewsMary Ellen Schneider
Biologics/ biosimilars/ vaccinesClinical TrialsPharmaceuticalsUnited StatesRegulatory NewsMary Ellen SchneiderBiologics/ biosimilars/ vaccinesClinical TrialsPharmaceuticalsUnited States